Zelluna ImmunotherapyZelluna Immunotherapy is a privately owned Norwegian biopharmaceutical company.
Suggest an EditAbout Zelluna Immunotherapy
Zelluna Immunotherapy AS is a privately owned Norwegian biopharmaceutical company founded in 2016 focused on the development of TCR based immunotherapies.
Our goal is to revolutionize cancer therapy by developing TCR based therapies with the potential to treat a wide range of cancer types and patients.
Zelluna’s core asset is a wide range of TCRs isolated from patients who exhibited long-term survival following inclusion in peptide based cancer vaccine trials initiated by Prof Gustav Gaudernac
Zelluna Immunotherapy AS is a privately owned Norwegian biopharmaceutical company founded in 2016 focused on the development of TCR based immunotherapies. Our goal is to revolutionize cancer therapy by developing TCR based therapies with the potential to treat a wide range of cancer types and patients. Zelluna’s core asset is a wide range of TCRs isolated from patients who exhibited long-term survival following inclusion in peptide based cancer vaccine trials initiated by Prof Gustav Gaudernac
Company Highlights
Employees
Total Investment Amt
YoY Headcount Growth
Year Founded
2016
Employees25
Location (HQ)
NOR
Since Last Funding
2 years
Monthly Website Visitors
8.7K
Total Investment Amt$8.5M
Last Funding Round
Series Unknown
YoY Headcount Growth-3.83%
Key Metrics
Senior Hires
| Name | Linkedin Profile | Position | Date Joined |
|---|---|---|---|
| John Doe | https://www.linkedin.com/in/johndoe | CEO | CEO |
| Jane Doe | https://www.linkedin.com/in/janedoe | CTO | CTO |
| John Smith | https://www.linkedin.com/in/johnsmith | CFO | CFO |
| Jane Smith | https://www.linkedin.com/in/janesmith | COO | COO |
Similar Companies
- Lion TCRArcus BiosciencesJuno TherapeuticsUmoja BiopharmaTCR2TScan TherapeuticsCogent BiosciencesTmunity TherapeuticsImmunitas TherapeuticsJounce TherapeuticsTriumvira ImmunologicsPionyr ImmunotherapeuticsTallac TherapeuticsNohla TherapeuticsCellenkosAleta BiotherapeuticsImmunoGenesis2seventy bioExcellosImmunocoreQuell TherapeuticsAutolusZiopharm oncologyEnara BioCellerant TherapeuticsImmunoCellular TherapeuticsEngimmune TherapeuticsOSE ImmunotherapeuticsXNK TherapeuticsiOncturaAsgard TherapeuticsBrenus PharmaEureka Therapeutics, Inc.Gracell BiotechnologiesImmuneel TherapeuticsJW TherapeuticsUltimovacsSELLAS Life SciencesTCR CureTargovaxOricell TherapeuticsImmunicumTessa TherapeuticsTxCellZura BioCellectisCello TherapeuticsNEukio BiotherapeuticsNeoImmuneTechElicera TherapeuticsTusk TherapeuticsAlzinova AB
Medical
Biotechnology
- NEC OncoImmunity ASNEC OncoImmunity ASThalassoCimon MedicalArcticZymes Technologies ASAArcticZymes Technologies ASAPlanktonic ASPlanktonic ASHadean VenturesClexBioLytix BiopharmaLytix BiopharmaOtivioGenetic AnalysisBerGenBioNorwegian Mycelium (NoMy)S*BioUltimovacsUltimovacsTargovaxTargovaxCalluna PharmaCytovationVectron BiosolutionsVectron BiosolutionsArctic BioscienceArctic Biosciencebeefutures.ioNextera ASBio-MeSeaweed Solutions
Health Care
- NEC OncoImmunity ASOiviSensocureSFDClexBioGlucoSetCheckWareLytix BiopharmaOtivioEyrUltimovacsTargovaxLIFENESSAbly MedicalNorse FeedbackbbhugmeXEEDLifekeysMode SensorsLivv HealthVectron BiosolutionsHjemmelegeneObserve MedicalHoloCareNextera ASYatekDiffiaPicterusGjensidigestiftelsenNorway Health TechResaniFSi
Biotechnology Research